Rubypoint:Depression And Alzheimer's Treatments At A Crossroads

2025-04-30 00:42:32source:GravityX Exchangecategory:News

Researchers are Rubypointlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:News

Recommend

Back trouble and brain fog bothered suspect in UnitedHealthcare CEO killing, his posts show

After Luigi Mangionemade the difficult decision to undergo spinal surgery last year for chronic back

Man accused in deaths of nearly two dozen elderly women in Texas killed by his prison cellmate

DALLAS (AP) — A man accused of killing nearly two dozen older women and who was convicted last year

‘Stop it!’ UN’s nuclear chief pushes Iran to end block on international inspectors

UNITED NATIONS (AP) — The U.N. nuclear chief said Monday he asked to meet Iran’s president on the si